sepsis more than two decades in the making is another step closer to reality, with the launch of a clinical trial involving COVID-19 patients in London, Ont.Lawson Health Research Institute says enrolment for the clinical trial is already underway, with a goal of including 60 critically ill COVID-19 patients.If the trial results show promise, Lawson scientist Dr.
Qingping Feng’s team plans to expand to a larger phase III trial involving “not just COVID-19 patients with sepsis, but other sepsis patients as well.” Potential sepsis treatment could be ready in 5 years thanks to London, Ont., researcher Sepsis is a potentially fatal condition wherein the body overreacts to an infection, leading to an overwhelming inflammatory response that can.